Correction to: A novel SLC8A1/LINC01913 intergenic region-ALK fusion identified by NGS and validated by IHC and FISH in a stage IIB lung adenocarcinoma patient who remains relapse-free during the treatment of crizotinib: A case report
-
Published:2022-08-16
Issue:6
Volume:40
Page:1357-1357
-
ISSN:0167-6997
-
Container-title:Investigational New Drugs
-
language:en
-
Short-container-title:Invest New Drugs
Author:
Wang Chunguang,Chen Shu,He Qianru,Sun Tingting,Xu Peiran
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology